UY27712A1 - Indazoles sustituidos, composiciones que los contienen, procedimientos de fabricación y utilización - Google Patents
Indazoles sustituidos, composiciones que los contienen, procedimientos de fabricación y utilizaciónInfo
- Publication number
- UY27712A1 UY27712A1 UY27712A UY27712A UY27712A1 UY 27712 A1 UY27712 A1 UY 27712A1 UY 27712 A UY27712 A UY 27712A UY 27712 A UY27712 A UY 27712A UY 27712 A1 UY27712 A1 UY 27712A1
- Authority
- UY
- Uruguay
- Prior art keywords
- manufacturing
- compositions
- indazols
- replaced
- contain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Indazoles substituidos, composiciones que los contienen, procedimiento para la fabricación y utilización. La presente invención se refiere, en particular, a nuevos indazoles sustituidos específicos, que presentan una actividad inhibidora de kinasas, que tienen una actividad terapéutica, en particular en oncologia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0202996A FR2836914B1 (fr) | 2002-03-11 | 2002-03-11 | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27712A1 true UY27712A1 (es) | 2003-09-30 |
Family
ID=27763684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27712A UY27712A1 (es) | 2002-03-11 | 2003-03-11 | Indazoles sustituidos, composiciones que los contienen, procedimientos de fabricación y utilización |
Country Status (29)
Country | Link |
---|---|
US (2) | US6858638B2 (es) |
EP (1) | EP1487803A1 (es) |
JP (1) | JP4643910B2 (es) |
KR (1) | KR20040091128A (es) |
CN (1) | CN100369899C (es) |
AR (1) | AR038914A1 (es) |
AU (1) | AU2003242808B2 (es) |
BR (1) | BR0308339A (es) |
CA (1) | CA2478540A1 (es) |
EC (1) | ECSP045286A (es) |
FR (1) | FR2836914B1 (es) |
GT (1) | GT200300031A (es) |
HN (1) | HN2003000094A (es) |
HR (1) | HRP20040825A2 (es) |
IL (2) | IL163805A0 (es) |
MA (1) | MA27176A1 (es) |
MX (1) | MXPA04008446A (es) |
NO (1) | NO20044261L (es) |
OA (1) | OA12784A (es) |
PA (1) | PA8566701A1 (es) |
PE (1) | PE20040071A1 (es) |
PL (1) | PL372389A1 (es) |
RU (1) | RU2004130280A (es) |
SV (1) | SV2003001493A (es) |
TN (1) | TNSN04175A1 (es) |
TW (1) | TW200303863A (es) |
UY (1) | UY27712A1 (es) |
WO (1) | WO2003078402A1 (es) |
ZA (1) | ZA200406730B (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2836914B1 (fr) * | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
GB0218625D0 (en) * | 2002-08-10 | 2002-09-18 | Astex Technology Ltd | Pharmaceutical compounds |
US7262200B2 (en) | 2002-10-25 | 2007-08-28 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
WO2005014554A1 (en) * | 2003-08-08 | 2005-02-17 | Astex Therapeutics Limited | 1h-indazole-3-carboxamide compounds as mapkap kinase modulators |
FR2864084B1 (fr) | 2003-12-17 | 2006-02-10 | Aventis Pharma Sa | Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments |
EP1694686A1 (en) * | 2003-12-19 | 2006-08-30 | Takeda San Diego, Inc. | Kinase inhibitors |
GB0330042D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them |
GB0330043D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them |
EP1763524A1 (en) * | 2004-04-23 | 2007-03-21 | Takeda San Diego, Inc. | Indole derivatives and use thereof as kinase inhibitors |
JP2008510734A (ja) * | 2004-08-18 | 2008-04-10 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
RU2392272C2 (ru) * | 2004-09-29 | 2010-06-20 | Ф.Хоффманн-Ля Рош Аг | Производные индазолона в качестве ингибиторов 11b-hsd1 |
US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
SE0402763D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Nitro indazole derivatives |
SE0402762D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Indazole sulphonamide derivatives |
WO2007023114A1 (en) * | 2005-08-25 | 2007-03-01 | F. Hoffmann-La Roche Ag | P38 map kinase inhibitors and methods for using the same |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
DK1981851T3 (da) | 2006-01-31 | 2012-03-19 | Array Biopharma Inc | Kinaseinhibitorer og fremgangsmåder til anvendelse deraf |
US20100120717A1 (en) | 2006-10-09 | 2010-05-13 | Brown Jason W | Kinase inhibitors |
EP2223925A1 (en) * | 2006-10-09 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
WO2008063888A2 (en) * | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
FR2917735B1 (fr) * | 2007-06-21 | 2009-09-04 | Sanofi Aventis Sa | Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique |
JP5364875B2 (ja) * | 2007-07-16 | 2013-12-11 | アッヴィ・インコーポレイテッド | タンパク質キナーゼ阻害薬としてのインダゾール類、ベンゾイソオキサゾール類およびベンゾイソチアゾール類 |
US9034875B2 (en) | 2009-05-26 | 2015-05-19 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
SG175253A1 (en) * | 2009-05-26 | 2011-11-28 | Abbott Lab | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
US8546399B2 (en) | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
US20220315555A1 (en) | 2009-05-26 | 2022-10-06 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
WO2011050245A1 (en) * | 2009-10-23 | 2011-04-28 | Yangbo Feng | Bicyclic heteroaryls as kinase inhibitors |
CN102247361B (zh) * | 2010-05-20 | 2015-04-29 | 中国医学科学院药物研究所 | 5-硝基-1氢-吲唑-3-腈在制备药物中的应用 |
UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
KR102095698B1 (ko) | 2010-10-29 | 2020-04-01 | 애브비 인코포레이티드 | 아폽토시스―유도제를 포함하는 고체 분산체 |
ES2603129T3 (es) | 2010-11-23 | 2017-02-23 | Abbvie Ireland Unlimited Company | Métodos de tratamiento utilizando inhibidores selectivos de Bcl-2 |
DK2643322T3 (en) | 2010-11-23 | 2017-12-11 | Abbvie Inc | SALTS AND CRYSTAL FORMS OF AN APOPTOSIS-INducing Agent |
US20140275082A1 (en) | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
MX2017005719A (es) * | 2014-11-03 | 2017-12-07 | Iomet Pharma Ltd | Compuesto farmaceutico. |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
CN111278437A (zh) * | 2017-07-21 | 2020-06-12 | 卡德门企业有限公司 | Rho相关含卷曲螺旋蛋白激酶的抑制剂 |
US11186549B2 (en) | 2017-08-29 | 2021-11-30 | Rutgers, The State University Of New Jersey | Therapeutic indazoles |
WO2023137041A1 (en) * | 2022-01-12 | 2023-07-20 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
CN114605329B (zh) * | 2022-03-28 | 2024-01-26 | 河南中医药大学 | 取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS514505Y2 (es) | 1971-02-13 | 1976-02-07 | ||
JPH061350B2 (ja) * | 1985-07-26 | 1994-01-05 | コニカ株式会社 | ハロゲン化銀写真感光材料 |
EA001367B1 (ru) | 1996-02-22 | 2001-02-26 | Туларик, Инк. | Пентафторбензолсульфонамиды и их аналоги |
IL127965A0 (en) * | 1996-07-19 | 1999-11-30 | Tularik Inc | Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
US6087368A (en) * | 1998-06-08 | 2000-07-11 | Bristol-Myers Squibb Company | Quinazolinone inhibitors of cGMP phosphodiesterase |
AU1818400A (en) | 1998-11-12 | 2000-05-29 | Eli Lilly And Company | Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles |
CO5170498A1 (es) * | 1999-05-28 | 2002-06-27 | Abbott Lab | Biaril sulfonamidas son utiles como inhibidores de proliferacion celular |
YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
KR100423899B1 (ko) * | 2000-05-10 | 2004-03-24 | 주식회사 엘지생명과학 | 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸 |
US6897231B2 (en) * | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
JP4535680B2 (ja) * | 2001-04-16 | 2010-09-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 新規1h−インダゾール化合物 |
EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
US7064215B2 (en) * | 2001-07-03 | 2006-06-20 | Chiron Corporation | Indazole benzimidazole compounds |
WO2003024969A1 (en) | 2001-09-14 | 2003-03-27 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
FR2836914B1 (fr) * | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
-
2002
- 2002-03-11 FR FR0202996A patent/FR2836914B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-06 GT GT200300031A patent/GT200300031A/es unknown
- 2003-02-13 PA PA20038566701A patent/PA8566701A1/es unknown
- 2003-02-24 TW TW092103799A patent/TW200303863A/zh unknown
- 2003-03-03 SV SV2003001493A patent/SV2003001493A/es not_active Application Discontinuation
- 2003-03-07 PL PL03372389A patent/PL372389A1/xx not_active Application Discontinuation
- 2003-03-07 JP JP2003576408A patent/JP4643910B2/ja not_active Expired - Fee Related
- 2003-03-07 KR KR10-2004-7014298A patent/KR20040091128A/ko not_active Application Discontinuation
- 2003-03-07 BR BR0308339-0A patent/BR0308339A/pt not_active IP Right Cessation
- 2003-03-07 MX MXPA04008446A patent/MXPA04008446A/es active IP Right Grant
- 2003-03-07 AU AU2003242808A patent/AU2003242808B2/en not_active Ceased
- 2003-03-07 OA OA1200400236A patent/OA12784A/fr unknown
- 2003-03-07 WO PCT/FR2003/000751 patent/WO2003078402A1/fr active Application Filing
- 2003-03-07 RU RU2004130280/04A patent/RU2004130280A/ru not_active Application Discontinuation
- 2003-03-07 EP EP03744395A patent/EP1487803A1/fr not_active Withdrawn
- 2003-03-07 PE PE2003000232A patent/PE20040071A1/es not_active Application Discontinuation
- 2003-03-07 IL IL16380503A patent/IL163805A0/xx unknown
- 2003-03-07 CA CA002478540A patent/CA2478540A1/fr not_active Abandoned
- 2003-03-07 CN CNB038058731A patent/CN100369899C/zh not_active Expired - Fee Related
- 2003-03-10 HN HN2003000094A patent/HN2003000094A/es unknown
- 2003-03-10 AR ARP030100807A patent/AR038914A1/es unknown
- 2003-03-11 UY UY27712A patent/UY27712A1/es unknown
- 2003-03-11 US US10/385,870 patent/US6858638B2/en not_active Expired - Lifetime
-
2004
- 2004-08-12 MA MA27825A patent/MA27176A1/fr unknown
- 2004-08-24 ZA ZA200406730A patent/ZA200406730B/en unknown
- 2004-08-30 IL IL163805A patent/IL163805A/en not_active IP Right Cessation
- 2004-09-10 TN TNP2004000175A patent/TNSN04175A1/fr unknown
- 2004-09-10 EC EC2004005286A patent/ECSP045286A/es unknown
- 2004-09-10 HR HR20040825A patent/HRP20040825A2/hr not_active Application Discontinuation
- 2004-10-07 NO NO20044261A patent/NO20044261L/no unknown
- 2004-10-13 US US10/963,880 patent/US7473701B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27712A1 (es) | Indazoles sustituidos, composiciones que los contienen, procedimientos de fabricación y utilización | |
UY28941A1 (es) | Indazoles sustituidos, composiciones que los contienen, procedimiento de preparacion y su uso | |
DOP2010000134A (es) | Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos | |
ECSP066365A (es) | Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk | |
UY29796A1 (es) | Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor | |
NO20072558L (no) | Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav | |
CR8766A (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
CR9580A (es) | Inhibidores de la actividad akt | |
ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
UY27222A1 (es) | Pirazolopirimidinas como agentes terapéuticos | |
UY27729A1 (es) | Inhibidores de quinasas. | |
ECSP099378A (es) | Compuestos y composiciones como inhibidores de la proteina quinasa | |
SG153851A1 (en) | N-(1-(1-benzyl -4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer | |
GT200900283A (es) | "terapia de combinación con un compuesto actuando como un inhibidor del receptor adp plaquetario". | |
NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
UY28514A1 (es) | Nuevos compuestos | |
DK1641803T3 (da) | Thienopyrimidinderivater som kaliumkanalinhibitorer | |
ATE432281T1 (de) | Pyrrolotriazin-kinasehemmer | |
NO20076447L (no) | Bicykliske derivater som modulatorer av ionekanaler | |
NO20071742L (no) | Kinazoliner som er nyttige som modulatorer av ionekanaler | |
NO341679B1 (no) | Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren | |
NO20055612L (no) | Anti-inflammatoriske fosfonatforbindelser | |
UY28350A1 (es) | Productos aril-heteroaromaticos, composiciones que los contienen y su utilización | |
BRPI0511475A (pt) | combinação, composição farmacêutica, uso de uma combinação, e, método para o tratamento de cáncer | |
CL2007003251A1 (es) | Compuestos derivados de 1h-pirazoles sustituidos, inhibidores de reacciones catalizadas por una quinasa; su procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; uso de los compuestos principales, utiles en el tratamiento del cancer. |